NCT05777720

Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes

Name: Clinical Trial NCT05777720
Creator: Stanford University
Keywords: Covid19, Filtration Fan, device, clinical trial, United States of America

A Cluster-randomized Controlled Trial of Air Filtration and Ventilation Improvements to Reduce SARS CoV 2 Transmission Among Household Contacts

Stanford University·ClinicalTrials.gov·device·Device trialEnrolling by invitation

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Covid19
Drug/Device/Intervention: Filtration Fan
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: Stanford University
Location: San Mateo,Stanford, United States of America

Timeline & enrollment

Phase: N/A
Start date: Jan 30, 2023
End date: Jun 01, 2024
Enrollment: 200 participants

Primary outcome

Incidence of Covid19

Summary

Investigators are evaluating whether an intervention consisting of box-fans with MERV 16 filters (filtration fans) and recommendations for improving ventilation in the home can reduce secondary spread of Covid19 from an index case to susceptible contacts within the home.

ICD-10 classifications

COVID-19, virus identifiedCOVID-19, virus not identifiedCoronavirus infection, unspecified siteRift Valley feverPlague

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05777720
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT05777720 through Pure Global AI's free database. This phase not specified trial is sponsored by Stanford University and is currently Enrolling by invitation. The study focuses on Covid19. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.